Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neutropenia 1Neoplasms 1Mycoses 1HIV Infections 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 313atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Amphotericin B × Clear all
NCT01686607 2024-10-21

MYCOS

Astellas Pharma Inc

Completed
40,110 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00002277 2005-06-24

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

NIH AIDS Clinical Trials Information Service

Phase 3 Completed

Mycoses, Neoplasms, Neutropenia, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡